Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Hematologic Malignancies

ribavirin has been researched along with Hematologic Malignancies in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (10.00)18.2507
2000's7 (35.00)29.6817
2010's10 (50.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Chiu, CY; Hosing, C; Torres, HA; Westin, J; Zhang, HC1
Azzi, JM; Chemaly, RF; El Haddad, L; Ghantoji, SS; Heredia-Ariza, E; Kyvernitakis, A; Mahajan, SN; Shah, DP1
Aitken, C; Alric, L; Ayuk, F; Bettinger, D; Binder, M; Cornelissen, JJ; de Man, RA; Giordani, MT; Lohse, AW; Mallet, V; Pischke, S; Schlabe, S; Schnitzler, P; Spengler, U; Thimme, R; von Felden, J; Xhaard, A1
Jain, A; Jain, P; Kumar, A; Roy Moulik, N1
Ariza-Heredia, E; Champlin, RE; Chemaly, RF; El Taoum, KK; Ghantoji, SS; Mulanovich, V; Nunez, CA; Shah, DP; Shah, JN1
Boeckh, MJ; Chemaly, RF; Shah, DP1
Domínguez López, SL; Fernández Sierra, MA; Jiménez Romano, E; Molina Rueda, MJ1
Abravanel, F; Alric, L; Beyne-Rauzy, O; Faguer, S; Gaudin, C; Huguet, F; Huynh, A; Kamar, N; Oberic, L; Peron, JM; Recher, C; Roussel, M; Tavitian, S; Ysebaert, L1
Chin, J; Chu, HY; Englund, JA; Pollard, J; Zerr, DM1
Bode, U; Eis-Huebinger, AM; Panning, M; Schildgen, O; Simon, A1
Kuyumjian, AG; McCoy, D; Munk, GB; Sebti, R; Wong, E; Wynd, MA1
Hodson, A; Kasliwal, M; MacMahon, E; Raj, K; Streetly, M1
Boas, LS; da Rocha, IF; Dulley, FL; Machado, CM; Mendes, AV; Pannuti, CS; Santos, MF; Sturaro, D1
Buxbaum-Conradi, H; Jäger, G; Kolb, HJ; Schleuning, M1
Bibes, B; Briens, E; Dauriac, C; Grosbois, B; Jego, P; Minjolle, S1
Caul, EO; Cornish, JM; Foot, AB; Grier, D; Kelly, C; Kingman, HM; Marks, DI; McCarthy, AJ; Moppett, J; Oakhill, A; Pamphilon, DH; Steward, CG; Taylor, GS1
Hamaguchi, M; Kanie, T; Kitaori, K; Kodera, Y; Kohno, A; Kojima, S; Matsuyama, T; Miyamura, K; Nagafuji, K; Saito, H; Sato, T; Taji, H; Tanimoto, M1
Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Preisegger, KH; Schwinger, W; Urban, C1
Hohenthal, U; Itälä, M; Kotilainen, P; Nikoskelainen, J; Peltonen, R; Routamaa, M; Vainionpää, R1
Chakrabarti, S; Collingham, KE; Fegan, CD; Holder, K; Milligan, DW; Osman, H1

Reviews

1 review(s) available for ribavirin and Hematologic Malignancies

ArticleYear
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Nov-15, Volume: 59 Suppl 5

    Topics: Antiviral Agents; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Influenza, Human; Paramyxoviridae Infections; Pneumonia, Viral; Recombinant Fusion Proteins; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Virus Diseases

2014

Trials

2 trial(s) available for ribavirin and Hematologic Malignancies

ArticleYear
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    Bone marrow transplantation, 1999, Volume: 24, Issue:12

    Topics: Adolescent; Adult; Child; Child, Preschool; Genotype; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Radiography, Thoracic; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Homologous; Treatment Outcome

1999
Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors.
    Bone marrow transplantation, 2000, Volume: 25, Issue:5

    Topics: Adenoviridae Infections; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Child; Cystitis; Female; Fever; Hematologic Neoplasms; Hemorrhage; Histocompatibility; HLA Antigens; Humans; Male; Nuclear Family; Pancytopenia; Ribavirin; Survival Rate; Tissue Donors; Transplantation, Homologous

2000

Other Studies

17 other study(ies) available for ribavirin and Hematologic Malignancies

ArticleYear
Hepatitis E Virus Infection in Cancer Patients.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:11

    Topics: Adult; Female; Hematologic Neoplasms; Hepatitis E; Hepatitis E virus; Humans; Male; Neoplasms; Retrospective Studies; Ribavirin; RNA; United States; Viremia

2022
Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
    The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hematologic Neoplasms; Humans; Leukopenia; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Young Adult

2018
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    Journal of hepatology, 2019, Volume: 71, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Ribavirin; Rituximab; RNA, Viral; Survival Rate; Young Adult

2019
Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:10

    Topics: Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Disease Outbreaks; Female; Hematologic Neoplasms; Humans; Immunoglobulin M; Infant; Male; Measles; Ribavirin; RNA, Viral

2013
Respiratory syncytial virus infections in children with cancer.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:6

    Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome

2014
[Approach to a respiratory syncytial virus outbreak related to medical care in hematology].
    Enfermedades infecciosas y microbiologia clinica, 2015, Volume: 33, Issue:8

    Topics: Adult; Antiviral Agents; Bronchial Spasm; Cross Infection; Disease Outbreaks; Disease Susceptibility; Female; Hand Hygiene; Hematologic Neoplasms; Hematology; Hospital Departments; Hospitals, University; Humans; Infection Control; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin

2015
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.
    Emerging infectious diseases, 2015, Volume: 21, Issue:8

    Topics: Antiviral Agents; Hematologic Neoplasms; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Ribavirin

2015
Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.
    Influenza and other respiratory viruses, 2016, Volume: 10, Issue:3

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Male; Outpatients; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; Risk Factors; Transplantation; Treatment Outcome; United States; Young Adult

2016
Respiratory syncytial virus infection in patients with cancer: still more questions than answers.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jun-15, Volume: 46, Issue:12

    Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Infant; Male; Neoplasms; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin

2008
Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin

2011
A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.
    Bone marrow transplantation, 2011, Volume: 46, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Disease Outbreaks; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Lung Diseases; Male; Middle Aged; Multiple Organ Failure; Parainfluenza Virus 3, Human; Respirovirus Infections; Ribavirin; Sepsis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous

2011
Low mortality rates related to respiratory virus infections after bone marrow transplantation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:8

    Topics: Acetamides; Aerosols; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Fluorescent Antibody Technique, Indirect; Hematologic Neoplasms; Humans; Influenza, Human; Oseltamivir; Paramyxoviridae Infections; Postoperative Complications; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous; Virus Shedding

2003
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:2

    Topics: Adenoviridae; Adenovirus Infections, Human; Adolescent; Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Gastrointestinal Tract; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory System; Ribavirin; Treatment Outcome

2004
[Respiratory syncytial virus pneumonia in four immunocompromised adults].
    La Revue de medecine interne, 1999, Volume: 20, Issue:10

    Topics: Antiviral Agents; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia; Respiratory Syncytial Virus Infections; Ribavirin

1999
Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy.
    Pediatrics, 2000, Volume: 106, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Child; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Pilot Projects; Recombinant Proteins; Ribavirin; RNA, Viral; Transaminases

2000
Parainfluenza virus type 3 infections in a hematology unit.
    Bone marrow transplantation, 2001, Volume: 27, Issue:3

    Topics: Adult; Aged; Antigens, Viral; Cross Infection; Female; Finland; Follow-Up Studies; Hematologic Neoplasms; Hematology; Hematopoietic Stem Cell Transplantation; Hospital Units; Humans; Immunocompromised Host; Male; Middle Aged; Parainfluenza Virus 3, Human; Paramyxoviridae Infections; Ribavirin

2001
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Administration, Oral; Adult; Anemia; Anemia, Aplastic; Antiviral Agents; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Nausea; Parainfluenza Virus 3, Human; Pilot Projects; Pneumonia, Viral; Population Surveillance; Prospective Studies; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation Conditioning; Treatment Outcome

2001